The
You inject from a vial with a small syringe instead of a pre-filled pen. Same medicine, lower price, no insurance paperwork.
Active: tirzepatide, titrated from a 2.5 mg starting dose to a clinically appropriate maintenance dose.
Excipients: sodium chloride, water for injection, and a sterile buffer system standard to injectable preparations.
Pharmacy: a U.S.-licensed 503A compounding pharmacy operating in an FDA-registered facility. Compounded preparations are not FDA-approved as finished products.
Draw your dose and inject
Your provider increases the dose every 4 weeks based on tolerance and progress — mirroring the branded titration protocol.
Tirzepatide is a Y-shaped molecule that docks into the GIP and GLP-1 receptors at the same time — a broader fullness signal than GLP-1 alone, which is why average results in trials run higher.
In SURMOUNT-1, tirzepatide 15 mg drove ~22.5% body-weight reduction at 72 weeks — roughly 1.5× the average GLP-1-only result and well clear of the ~2.4% placebo arm. Compounded preparations are not separately trialed.*
Pay $339/mo month-to-month, or lock the 52-week commit at $269/mo — that’s $70 less every month, $840 less every year. Cash pay, no prior auths, no insurer back-and-forth.
Join Teledris — $59/mo membership covers care, messaging, and dose adjustments. Cancel anytime.
Medication cost not included.A licensed U.S. provider reviews your intake and decides whether tirzepatide is the right call for you. Most days, under 24 hours.
If prescribed, you get a tailored titration schedule — starting dose, step-up cadence, and side-effect support. Cash pay, no insurer paperwork.
From prescription to your door in days, refrigerated. Cold-chain overnight where available. Refills auto-renew.
What you get with Teledris:
Compounded · 503A
Tirzepatide engages two appetite receptors — a broader fullness signal than GLP-1 alone. Compounded in the U.S. at a fraction of branded retail. Cash or insurance — your call.
Pricing
Membership required ($59/mo, cancel anytime). Medication billed separately at the tier you select. Coaching is bundled — already inside the price you see.
Both are once-weekly injections. Tirzepatide hits two appetite receptors instead of one, and trial averages run higher. Semaglutide has the longer weight-management track record.
Find my fit*An active Teledris membership is required ($59/mo, cancel anytime). Total cost includes the standard monthly membership fee and, if prescribed, the cost of medication. Membership and medication are billed separately. A prescription is not guaranteed. Medication is not available without an active membership.
1 SURMOUNT-OSA trial showed reduced obstructive sleep apnea events with tirzepatide at 52 weeks vs placebo. Compounded preparations are not separately trialed; talk to your provider.
It is prepared in a U.S.-licensed 503A compounding pharmacy operating in an FDA-registered, state-licensed facility. A licensed provider reviews your intake first and only prescribes if tirzepatide is the right call for you. Compounded preparations are not FDA-approved as finished products.
The active molecule is identical — tirzepatide, the same dual GIP + GLP-1 agonist.
The differences are commercial. Zepbound® is branded and ships as a pre-filled pen. Compounded tirzepatide ships as a vial-and-syringe kit from $269/mo cash. Compounded preparations are not FDA-approved as finished products.
The clinical evidence — SURMOUNT-1 and the broader SURMOUNT program — is on the tirzepatide molecule, and the molecule is the same in both preparations. Compounded versions are not separately trialed, so your provider tailors the titration to mirror the branded protocol.
No. It is cash pay — $339/mo month-to-month, or $269/mo on a 52-week commit. No prior auths, no insurer paperwork. If your insurance ever covers branded Zepbound, we can switch you to the branded pen.
Roughly 20 weeks to reach a typical maintenance dose. Most patients start at 2.5 mg and step up every 4 weeks under provider guidance, mirroring the branded protocol. Your provider may move faster or slower based on how your body responds.
Store the vial refrigerated (36–46°F / 2–8°C) until use. Do not freeze. Shipments arrive in insulated cold-chain packaging — refrigerate immediately on arrival.
Once in use, follow your provider and pharmacy guidance on beyond-use dating. Never use a vial that has been frozen, left at room temperature for an extended stretch, or looks cloudy or discolored.
Adults 18+ in eligible states with a BMI of 30+, or 27+ with a weight-related condition. A licensed provider reviews your full intake and medical history to decide if tirzepatide is the right fit for you.
Florida, Texas, and California today. More states are rolling out through the year. If we are not in yours yet, leave your email and we will tell you the day we are.
The most common side effects are gastrointestinal — nausea, mild diarrhea, constipation, and reduced appetite — and most ease as the body adjusts. Slow titration is designed to minimize them.
Message your provider through the app whenever you need to. Care messaging is included in the $59/mo membership, with 24/7 access for urgent questions.
GLP-1s are intended for long-term use. When the medication stops, the appetite signals it was suppressing can return and weight regain is common. Always talk to your provider before stopping or pausing.
